Skip to content
Contact Us
0
IDKmonitor Adalimumab TOTAL anti-drug antibody assay
Back To Our Shop

Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

Category:

Key Advantages

Supports the investigation of primary non-response and loss of response to adalimumab

Highly sensitive drug tolerant assay that detects total anti-adalimumab antibodies (those free and bound to adalimumab)

May help to predict long term outcome of disease

Identifies patients with low-titre anti-adalimumab antibodies

Applicable to both gastroenterology and rheumatology

Automatable on ELISA automates (e.g. Dynex D2)

Determination of total anti-adalimumab antibodies

Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.

The assay is widely available throughout the UK and Ireland to both routine clinical laboratories as well as for research applications. Please contact us for your nearest test reference laboratory. This kit is supported by UK publications and evidence base.

  • ELISA

  • 45 tests

  • Storage: 2-8 °C

  • Blood sample